Open access

DEVELOPMENT AND EVALUATION OF A MULTIMEDIA TOOL FOR OBTAINING INFORMED CONSENT IN THE GAMBIA: A MIXED METHOD STUDY
Muhammed Afolabi, Nuala Mcgrath, Umberto D'Alessandro, Beate Kampmann, Egeruan Imoukhuede, Raffaella Ravinetto, Neal Alexander, Heidi Larson, Daniel Chandramohan, Kalifa Bojang

BMJ Global Health Feb 2017, 2 (Suppl 2) A6-A7; DOI: 10.1136/bmjgh-2016-000260.13
IMPROVING THE EFFICIENCY OF AFRICAN RESEARCH ETHICS COMMITTEES AND STANDARDISING ETHICS REVIEW PROCESSES THROUGH AN AUTOMATED REVIEW PLATFORM
Boitumelo Mokgatla, Prince Bahati, Carel Ijsselmuiden

BMJ Global Health Feb 2017, 2 (Suppl 2) A6; DOI: 10.1136/bmjgh-2016-000260.12
TRANSLATING ETHICS GUIDELINES ON COMPENSATION FOR RESEARCH-RELATED INJURIES INTO POLICY IN LOW-INCOME COUNTRIES: LESSONS LEARNT FROM MALAWI
Patrick Kamalo, Lucinda Manda-Taylor, Stuart Rennie

BMJ Global Health Feb 2017, 2 (Suppl 2) A6; DOI: 10.1136/bmjgh-2016-000260.11
PERFORMANCE OF XPERT MTB/RIF AND DETERMINE LAM IN HIV-INFECTED ADULTS IN PERI-URBAN SITES IN ZAMBIA (CDC OP-X STUDY)
Margaret Phiri Kasaro, Brenda Muluka, Kaunda Kaunda, Jill Morse, Andrew Westfall, Nathan Kapata, Annika Kruuner, German Henostroza, Stewart Reid

BMJ Global Health Feb 2017, 2 (Suppl 2) A7; DOI: 10.1136/bmjgh-2016-000260.14
COMPARATIVE EVALUATION OF GENOTYPE MTBDRPLUS VERSION 2 AND GENE XPERT MTB/RIF ASSAYS TO DETECT MYCOBACTERIUM TUBERCULOSIS AND RESISTANCE GENE PATTERNS IN GABON
Abraham Alabi, Francis Foguim, Jeyaraj Sankarganesh, Ellen Bruske, Arnault Mfoumbi, Chester Mevyann, Ayola Adegnika, Bertrand Lell, Katharina Kranzer, Peter Kremsner, Martin Grobusch

BMJ Global Health Feb 2017, 2 (Suppl 2) A7; DOI: 10.1136/bmjgh-2016-000260.15
PREVALENCE AND CLINICAL SIGNIFICANCE OF SCHISTOSOMIASIS-CHRONIC HEPATITIS B VIRUS CO-INFECTION IN ZAMBIA
Caroline Chisenga, Edford Sinkala, Roma Chilengi, Hellen Chitundu, Zude Zyambo, Gilles Wandeler, Michael Vinikoor

BMJ Global Health Feb 2017, 2 (Suppl 2) A8-A9; DOI: 10.1136/bmjgh-2016-000260.18
DIAGNOSTIC TOOLS FOR HUMAN AFRICAN TRYPANOSOMIASIS ELIMINATION AND CLINICAL TRIALS: THE DITECT-HAT PROJECT
Veerle Lejon, Hamidou Ilboudo, Dieudonné Mumba, Mamady Camara, Dramane Kaba, Crispin Lumbala, Eric Fèvre, Vincent Jamonneau, Bruno Bucheton, Philippe Büscher

BMJ Global Health Feb 2017, 2 (Suppl 2) A8; DOI: 10.1136/bmjgh-2016-000260.17
MOLECULAR BACTERIAL LOAD ASSAY: A FAST AND ACCURATE MEANS FOR MONITORING TUBERCULOSIS TREATMENT RESPONSE
Wilber Sabiiti, Nyanda Ntinginya, Davis Kuchaka, Khalide Azam, Elizabeth Kampira, Bariki Mtafya, Ruth Bowness, Nilesh Bhatt, Gerry Davies, Gibson Kibiki, Stephen Gillespie

BMJ Global Health Feb 2017, 2 (Suppl 2) A8; DOI: 10.1136/bmjgh-2016-000260.16
VIROLOGICAL RESPONSE TO EARLY COMBINED ANTIRETROVIRAL THERAPY IN HIV-INFECTED INFANTS: EVALUATION AFTER TWO YEARS OF TREATMENT IN THE PEDIACAM STUDY
Francis Ateba Ndongo, Mathurin Cyrille Tejiokem, Gaetan Texier, Calixte Penda, Suzie Ndiang, Jean-Audrey Ndongo, Georgette Guemkam, Casimir Ledoux Sofeu, Kfutwa Afumbom, Albert Faye, Philippe Msellati, Josiane Warszawski

BMJ Global Health Feb 2017, 2 (Suppl 2) A9-A10; DOI: 10.1136/bmjgh-2016-000260.21
PREVALENCE AND RISK FACTORS OF VIROLOGICAL FAILURE AMONG CHILDREN ON ANTIRETROVIRAL THERAPY
Michael Owusu, Eric Mensah, Anthony Enimil, Mohamed Mutocheluh

BMJ Global Health Feb 2017, 2 (Suppl 2) A9; DOI: 10.1136/bmjgh-2016-000260.20

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages